Prime Medicine Statistics Share Statistics Prime Medicine has 178.2M
shares outstanding. The number of shares has increased by 9.38%
in one year.
Shares Outstanding 178.2M Shares Change (YoY) 9.38% Shares Change (QoQ) 0.1% Owned by Institutions (%) 45.58% Shares Floating 63.94M Failed to Deliver (FTD) Shares 5,125 FTD / Avg. Volume 0.12%
Short Selling Information The latest short interest is 21.66M, so 16.11% of the outstanding
shares have been sold short.
Short Interest 21.66M Short % of Shares Out 16.11% Short % of Float 33.51% Short Ratio (days to cover) 3.35
Valuation Ratios The PE ratio is -1.77 and the forward
PE ratio is -3.78.
Prime Medicine's PEG ratio is
0.07.
PE Ratio -1.77 Forward PE -3.78 PS Ratio 116.1 Forward PS 22.2 PB Ratio 2.26 P/FCF Ratio -2.66 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Prime Medicine.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.58,
with a Debt / Equity ratio of 0.27.
Current Ratio 5.58 Quick Ratio 5.58 Debt / Equity 0.27 Debt / EBITDA -0.21 Debt / FCF -0.31 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $13.94K Profits Per Employee $-915.34K Employee Count 214 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -15.01% in the
last 52 weeks. The beta is 2.41, so Prime Medicine's
price volatility has been higher than the market average.
Beta 2.41 52-Week Price Change -15.01% 50-Day Moving Average 3.05 200-Day Moving Average 2.68 Relative Strength Index (RSI) 49.73 Average Volume (20 Days) 4,125,120
Income Statement In the last 12 months, Prime Medicine had revenue of 2.98M
and earned -195.88M
in profits. Earnings per share was -1.65.
Revenue 2.98M Gross Profit 2.98M Operating Income -202.47M Net Income -195.88M EBITDA -196.34M EBIT -202.47M Earnings Per Share (EPS) -1.65
Full Income Statement Balance Sheet The company has 182.48M in cash and 40.79M in
debt, giving a net cash position of 141.68M.
Cash & Cash Equivalents 182.48M Total Debt 40.79M Net Cash 141.68M Retained Earnings -687.21M Total Assets 279.01M Working Capital 87.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -122.86M
and capital expenditures -7.29M, giving a free cash flow of -130.16M.
Operating Cash Flow -122.86M Capital Expenditures -7.29M Free Cash Flow -130.16M FCF Per Share -1.1
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -6787.36% and -6566.61%.
Gross Margin 100% Operating Margin -6787.36% Pretax Margin -6566.61% Profit Margin -6566.61% EBITDA Margin -6581.93% EBIT Margin -6787.36% FCF Margin -4363.36%
